USANA HEALTH SCIENCES, INC. (NYSE:USNA) Files An 8-K Results of Operations and Financial Condition

Item 2.02

On May 2, 2017, USANA Health Sciences, Inc. (the Company or
USANA) issued a press release announcing its financial results
for the first quarter and three months ended April 1, 2017. The
release also announced that the Company will post a document
titled Management Commentary, Results and Outlook on the Companys
website and that executives of the company would hold a
conference call with investors, to be broadcast over the World
Wide Web and by telephone and provided access information, date
and time for the conference call. The Company noted that the call
will consist of brief remarks by the Companys management team,
before moving directly into questions and answers. A copy of the
press release, and the Management Commentary, Results and
Outlook, are furnished herewith as Exhibits to this Current
Report on Form 8-K and are incorporated herein by reference.
These documents will be posted on the Companys corporate website,
www.usanahealthsciences.com.

The information in this Current Report is being furnished and
shall not be deemed filed for the purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject
to the liabilities of that Section. The information in this
Current Report shall not be incorporated by reference into any
registration statement or other document to the Securities Act of
1933, as amended. The furnishing of the information in this
Current Report is not intended to, and does not, constitute a
representation that such furnishing is required by Regulation FD
or that the information this Current Report contains is material
investor information that is not otherwise publicly available.

(c)

On May 2, 2017, the Company announced, effective immediately,
that G. Douglas Hekking, 47, has been promoted from Executive
Vice President of Finance, a position which he has held since May
2016, to Chief Financial Officer. Mr. Hekking, 47, joined USANA
in 1992 and served the Company in several management positions
until March 1996, when he was appointed as Controller. Mr.
Hekking served as Controller from March 1996 until February 2005
when he was appointed as Vice President of Finance. He served as
Vice President of Finance until July 2007, when he transitioned
to USANAs operations group and was appointed as Executive
Director of Special Projects. He served in this position until
May 2011, when he was promoted to Chief Financial Officer. Mr.
Hekking served in this role until December 2012, when he stepped
aside to attend to certain family health matters. In December
2012, Mr. Hekking was appointed as Vice President of Finance and
served in this role until May 2016, when he was appointed as
Executive Vice President of Finance. Mr. Hekking received a B.S.
in accounting from the University of Utah and an M.B.A. from
Brigham Young University.

Mr. Hekking and the Company have agreed on the principal terms of
his employment as the Companys Chief Financial Officer. Mr.
Hekking will receive an annual salary of $415,000, which will be
reviewed going forward by the Compensation Committee. He will
also continue to be eligible to participate in the Companys
Executive Bonus Plan and receive equity grants under the Companys
2015 Equity Incentive Award Plan. Mr. Hekking will also be
eligible to participate in the Companys 401(k) plan and to
receive medical and other benefits coverage, which is generally
available to the Companys other employees.

The information disclosed above under Item 2.02, as well as the
exhibits attached under Item 9.01 below are incorporated herein
by reference.

About USANA HEALTH SCIENCES, INC. (NYSE:USNA)

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. It operates as a direct selling company in approximately two geographic regions: Americas and Europe, and Asia Pacific, which includes approximately three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of body nutrition for every age group. Its Foods product line includes low-glycemic meal replacement shakes and snack bars. Its Optimizers product line offers targeted supplements, which meets individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair. Its All Other product line includes materials and online tools that assists its network marketing system of independent distributors (Associates) in building their businesses and in marketing its products.

USANA HEALTH SCIENCES, INC. (NYSE:USNA) Recent Trading Information

USANA HEALTH SCIENCES, INC. (NYSE:USNA) closed its last trading session up +0.55 at 56.40 with 298,264 shares trading hands.